DK358875A - - Google Patents

Info

Publication number
DK358875A
DK358875A DK358875A DK358875A DK358875A DK 358875 A DK358875 A DK 358875A DK 358875 A DK358875 A DK 358875A DK 358875 A DK358875 A DK 358875A DK 358875 A DK358875 A DK 358875A
Authority
DK
Denmark
Application number
DK358875A
Other languages
Danish (da)
Other versions
DK139101C (https=
DK139101B (da
Inventor
C Casagrande
G Ferrari
Original Assignee
Siphar S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siphar S A filed Critical Siphar S A
Publication of DK358875A publication Critical patent/DK358875A/da
Publication of DK139101B publication Critical patent/DK139101B/da
Application granted granted Critical
Publication of DK139101C publication Critical patent/DK139101C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK358875AA 1974-08-08 1975-08-07 Analogifremgangsmåde til fremstilling af 3beta,14beta-dihydroxy-17beta-(4-pyridazinyl)-5beta-androstan-forbindelser. DK139101B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1085574A CH621803A5 (https=) 1974-08-08 1974-08-08

Publications (3)

Publication Number Publication Date
DK358875A true DK358875A (https=) 1976-02-09
DK139101B DK139101B (da) 1978-12-18
DK139101C DK139101C (https=) 1979-05-21

Family

ID=4367535

Family Applications (1)

Application Number Title Priority Date Filing Date
DK358875AA DK139101B (da) 1974-08-08 1975-08-07 Analogifremgangsmåde til fremstilling af 3beta,14beta-dihydroxy-17beta-(4-pyridazinyl)-5beta-androstan-forbindelser.

Country Status (12)

Country Link
US (1) US4000125A (https=)
JP (1) JPS5141372A (https=)
AR (1) AR217617A1 (https=)
BE (1) BE832271A (https=)
CA (1) CA1049499A (https=)
CH (1) CH621803A5 (https=)
DE (1) DE2534981A1 (https=)
DK (1) DK139101B (https=)
ES (1) ES440110A1 (https=)
FR (1) FR2281124A1 (https=)
GB (1) GB1484655A (https=)
SE (1) SE418401B (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1144136B (it) * 1980-03-05 1986-10-29 Zenyaku Kogyo Kk Glucosidi di condurango agenti antitumorali che li comprendono e procedimento per la loro preparazione
US5373095A (en) * 1985-10-18 1994-12-13 The Upjohn Company Steroid compounds
IT1262931B (it) * 1992-01-16 1996-07-22 Zambon Spa Composti steroidei 17(piridazin-n-ossido)-sostituiti attivi sul sistema cardiovascolare
DE4227616C2 (de) * 1992-08-20 1995-04-13 Sigma Tau Ind Farmaceuti 17-(3-Furyl)-und 17-(4-Pyridazinyl)-5beta, 14beta-androstanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammemsetzungen
US7875599B2 (en) * 2005-03-02 2011-01-25 University Of Maryland C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens, in vitro biological activities, pharmacokinetics and antitumor activity
GB2470873A (en) * 2008-03-12 2010-12-08 Univ Maryland Androgen receptor inactivation contributes to antitumor efficacy of CYP17 inhibitors in prostrate cancer
US20100048524A1 (en) * 2008-03-14 2010-02-25 Angela Brodie Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
GB2470700B (en) 2008-03-25 2012-08-08 Univ Maryland C-17 heteroaryl steroidal CYP17 inhibitors
US8785423B2 (en) * 2008-04-14 2014-07-22 University Of Maryland, Baltimore Compositions and methods of inducing endoplasmic reticulum stress response for the treatment of cell proliferative diseases
WO2010091303A1 (en) 2009-02-05 2010-08-12 Tokai Pharmaceuticals Novel steroidal cyp17 inhibitors/antiandrogens
WO2010091306A1 (en) 2009-02-05 2010-08-12 Tokai Pharmaceuticals Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens
WO2011017534A2 (en) 2009-08-07 2011-02-10 Tokai Pharmaceuticals, Inc. Treatment of prostate cancer
KR20150127720A (ko) 2013-03-14 2015-11-17 유니버시티 오브 매릴랜드, 발티모어 안드로겐 수용체 하향 조절제 및 그의 용도
CA2920317A1 (en) 2013-08-12 2015-02-19 Tokai Pharmaceuticals, Inc. Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies
WO2017001204A1 (en) * 2015-06-29 2017-01-05 Universiteit Gent Methods for the site-selective coupling of a first agent to a second agent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3838163A (en) * 1968-11-22 1974-09-24 Hoffmann La Roche Substituted isoxazole derivatives as steroid intermediates

Also Published As

Publication number Publication date
DK139101C (https=) 1979-05-21
CH621803A5 (https=) 1981-02-27
SE7508908L (sv) 1976-02-09
DE2534981A1 (de) 1976-02-19
FR2281124B1 (https=) 1980-05-16
JPS5141372A (https=) 1976-04-07
CA1049499A (en) 1979-02-27
BE832271A (fr) 1975-12-01
DK139101B (da) 1978-12-18
AR217617A1 (es) 1980-04-15
US4000125A (en) 1976-12-28
FR2281124A1 (fr) 1976-03-05
SE418401B (sv) 1981-05-25
ES440110A1 (es) 1977-02-16
GB1484655A (en) 1977-09-01

Similar Documents

Publication Publication Date Title
FR2281124B1 (https=)
DE2463455A1 (https=)
CS176483B1 (https=)
CS168310B1 (https=)
CS168449B1 (https=)
CH592241A5 (https=)
CH587493A5 (https=)
CH599712A5 (https=)
CH598194A5 (https=)
CH602619A5 (https=)
CH604378A5 (https=)
CH606144A5 (https=)
CH596126A5 (https=)
CH596117A5 (https=)
CH595568A5 (https=)
CH595477A5 (https=)
CH595328A5 (https=)
CH594752A5 (https=)
CH593738A5 (https=)
CH593160A5 (https=)
CH592893A5 (https=)
CH580842A5 (https=)
CH591895A5 (https=)
CH591334A5 (https=)
CH590601A5 (https=)